The role of p53-target genes in human cancer
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 33 (1) , 1-6
- https://doi.org/10.1016/s1040-8428(99)00051-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- GML sensitizes cancer cells to Taxol by induction of apoptosisOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Induction of the growth inhibitor IGF-binding protein 3 by p53Nature, 1995
- p53 tagged sites from human genomic DNAHuman Molecular Genetics, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- p53 Mutations in Human CancersScience, 1991